Overexpression of ABCA1, AGPAT1, and ACSL1 is associated with worse CRC outcomes, while ABCA1 and AGPAT1 are emphasized as predictors of a higher risk of CRC recurrence [136]. The gene discussed is ABCA1; the disease is colorectal carcinoma.